지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.7
- 수록면
- 41 - 47 (7page)
이용수
초록· 키워드
오류제보하기
This paper reports a presumptive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a cat. A cat with respiratory disease living with three individuals with coronavirus disease 2019 showed bilateral ground-glass opacities in the lung on X-ray and computed tomography. The clinical swabs were negative for SARS-CoV-2 RNA, but the serum was positive for SARS-CoV-2 antibodies. Interstitial pneumonia and prominent type 2 pneumocyte hyperplasia were noted on histopathology. Respiratory tissues were negative for SARS-CoV-2 RNA or antigen, but the cat was positive for feline parvovirus DNA. In conclusion, the respiratory disease and associated pathology in this cat could have been due to exposure to SARS-CoV-2.
목차
ABSTRACT
INTRODUCTION
CASE PRESENTATION
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea
Journal of Korean Medical Science
2021 .11
-
Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India
Osong Public Health and Research Persptectives
2021 .01
-
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
Immune Network
2021 .02
-
Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies
Annals of Laboratory Medicine
2022 .01
-
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
Annals of Laboratory Medicine
2021 .11
-
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
Infection and Chemotherapy
2021 .01
-
Virus Isolation from the First Patient with SARS-CoV-2 in Korea
Journal of Korean Medical Science
2020 .01
-
Isolation and Genomic Analyses of an Early SARS-CoV-2 Strains from the 2020 Epidemic in Gwangju, South Korea
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2021 .09
-
Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
Clinical and Experimental Vaccine Research
2023 .04
-
Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients
Kidney Research and Clinical Practice
2024 .05
-
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
Journal of Korean Medical Science
2023 .06
-
Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
Infection and Chemotherapy
2023 .03
-
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
Immune Network
2021 .10
-
Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
Journal of Korean Medical Science
2021 .01
-
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study
Yonsei Medical Journal
2020 .01
-
Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2020 .06
-
New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses
Annals of Laboratory Medicine
2024 .01
-
Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays
Annals of Laboratory Medicine
2023 .01
-
Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
Immune Network
2021 .04
-
COVID-19: Virological Perspective
한국실험동물학회 학술발표대회 논문집
2020 .07
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-528-001317314